Results 191 to 195 of about 5,013 (195)

Dexamethasone-sparing on days 2–4 with combined palonosetron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial)

British Journal of Cancer, 2023
H. Minatogawa, Naoki Izawa, K. Shimomura, Hitoshi Arioka, H. Iihara, Mitsuhiro Sugawara, H. Morita, Ayako Mochizuki, S. Nawata, Keisuke Mishima, A. Tsuboya, T. Miyaji, Kazunori Honda, Ayako Yokomizo, Naoya Hashimoto, Takeshi Yanagihara, J. Endo, T. Kawaguchi, Naoki Furuya, Yumiko Sone, Y. Inada, Y. Ohno, C. Katada, N. Hida, Kana Akiyama, Daisuke Ichikura, Akiko Konomatsu, Takashi Ogura, Takuhiro Yamaguchi, T. Nakajima   +29 more
semanticscholar   +1 more source

Comparing Palonosetron and Ondansetron for Preventing Post-Operative Nausea and Vomiting in Abdominal Surgery Patients

International Journal of Pharmaceutical Quality Assurance
Background: Postoperative nausea and vomiting (PONV) is a frequent and distressing complication following abdominal surgeries, affecting patient comfort and recovery. Ondansetron and palonosetron, both serotonin 5HT3 receptor antagonists, are widely used
Devesh Shukla, Ranjeet Kumar
semanticscholar   +1 more source

Protective Effect of Palonosetron against Cisplatin-Induced Cytotoxicity via Decreased Phosphorylation of p38.

Biological and Pharmaceutical Bulletin
The dose-limiting nephrotoxicity of cisplatin (CDDP) is attributed to its accumulation in renal epithelial cells, mediated by uptake via human organic cation transporter 2 (hOCT2) and efflux via human multidrug and toxin extrusion 1 (hMATE1), followed by
Masayoshi Kondo, Fumihiro Yamane, Kotaro Kawashima, K. Ikemura, Masahiro Okuda   +4 more
semanticscholar   +1 more source

Palonosetron for prevention of delayed chemotherapy-induced nausea and vomiting in pediatric patients: a meta-analysis

Supportive Care in Cancer, 2023
Atsushi Yamaguchi, Y. Saito, Y. Takekuma, M. Sugawara   +3 more
semanticscholar   +1 more source

Fosrolapitant/Palonosetron: First Approval

Drugs
Simon Fung
semanticscholar   +1 more source